Rheumatology Advance Access originally published online on January 7, 2008
Rheumatology 2008 47(3):382-383; doi:10.1093/rheumatology/kem346
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author 2008. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Comment on: Atorvastatin therapy improves endothelial-dependent vasodilation in patients with systemic lupus erythematosus: an 8 weeks controlled trial: reply
1Universidade Federal de Minas Gerais, Belo Horizonte and 2Universidade Federal de São Paulo, São Paulo, Brazil
Correspondence to: E. I. Sato, Rua Botucatu 740, CEP 040 23-900, São Paulo, Brazil. E-mail: emiliasato@reumato.epm.br
| The first 10% of the full text of this article appears below. |
SIR, We would like to thank Dr Kotyla [1] for their interest in our study. We agree that statins have a significant role in the modulation of the cytokines and are an important therapeutic option for patients